

NCT02590822 comparison:

Summary:
CHIA has 22 criteria while your personal folder has 22 criteria
Total found criteria: 22/22
Total not Found: 0/22
Total Extra: 2
This trial is VALID



╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╕
│ CHIA Criteria                                      │ Matching Personal Criteria                         │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╡
│ Capacity to provide informed consent before any    │ Capacity to provide informed consent before any    │
│ trial-related activities                           │ trial-related activities                           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Established T2DM (=3months)                        │ Established T2DM (≥3months)                        │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ HbA1c = 9% if on triple therapy or = 10% on diet & │ HbA1c ≤ 9% if on triple therapy or ≤ 10% on diet   │
│ exercise or monotherapy or dual therapy            │ \& exercise or monotherapy or dual therapy         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Current glucose lowering therapy either mono, dual │ Current glucose lowering therapy either mono, dual │
│ or triple of any combination of metformin,         │ or triple of any combination of metformin,         │
│ sulphonylurea, DPP-IV inhibitor, GLP-1 therapy or  │ sulphonylurea, DPP-IV inhibitor, GLP-1 therapy or  │
│ an SGLT2 +/- diet and exercise                     │ an SGLT2 +/- diet and exercise                     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Poorly managed diet controlled diabetes (with      │ Poorly managed diet controlled diabetes (with      │
│ HbA1c > 6.5% , not currently taking any glucose    │ HbA1c \> 6.5% , not currently taking any glucose   │
│ lowering therapy, meeting BMI inclusion range)     │ lowering therapy, meeting BMI inclusion range)     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Body mass index > 30Kg/m2 or > 27.5 Kg/m2 (South   │ Body mass index \> 30Kg/m2 or \> 27.5 Kg/m2 (South │
│ Asian)                                             │ Asian)                                             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Diagnosis of T2DM before the age of 60 years of    │ Diagnosis of T2DM before the age of 60 years of    │
│ age                                                │ age                                                │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Age =18 and = 65 years                             │ Age ≥18 and ≤ 65 years                             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ • Diabetes duration >12 years                      │ • Diabetes duration \>12 years                     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Currently taking more than three glucose lowering  │ Currently taking more than three glucose lowering  │
│ therapies                                          │ therapies                                          │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Weight-loss of >5kg in the preceding 6 months      │ Weight-loss of \>5kg in the preceding 6 months     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Stage 4 or 5 chronic kidney disease (eGFR<         │ Stage 4 or 5 chronic kidney disease (eGFR\<        │
│ 30ml/min/1.73m2)                                   │ 30ml/min/1.73m2)                                   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Current therapy with Insulin, thiazolidinediones,  │ Current therapy with Insulin, thiazolidinediones,  │
│ steroids or atypical antipsychotic medication      │ steroids or atypical antipsychotic medication      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Untreated thyroid disease                          │ Untreated thyroid disease                          │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Known macrovascular disease including coronary     │ Known macrovascular disease including coronary     │
│ artery disease, stroke/TIA or peripheral vascular  │ artery disease, stroke/TIA or peripheral vascular  │
│ disease                                            │ disease                                            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Presence of arrhythmia (including atrial           │ Presence of arrhythmia (including atrial           │
│ fibrillation, atrial flutter, or 2nd or 3rd degree │ fibrillation, atrial flutter, or 2nd or 3rd degree │
│ atrioventricular block)                            │ atrioventricular block)                            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Known heart failure                                │ Known heart failure                                │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Other clinically relevant heart disease            │ Other clinically relevant heart disease            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Inability to exercise or undertake a MRP           │ Inability to exercise or undertake a MRP           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Absolute contraindication to CMR                   │ Absolute contraindication to CMR                   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Cardiovascular symptoms (angina, limiting dyspnoea │ Cardiovascular symptoms (angina, limiting dyspnoea │
│ during normal physical activity)                   │ during normal physical activity)                   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Inflammatory condition e.g. Connective tissue      │ Inflammatory condition e.g. Connective tissue      │
│ disorder, Rheumatoid arthritis                     │ disorder, Rheumatoid arthritis                     │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╛



Everything was Found



╒═══════════════════════════════════╕
│ Extra Personal Criteria           │
╞═══════════════════════════════════╡
│ Must have minimum age of 18 Years │
├───────────────────────────────────┤
│ Must have maximum age of 65 Years │
╘═══════════════════════════════════╛